prodrug, yields small molecules that self-assemble in water to form supramolecular
hydrogels that undergo a gel-to-sol phase transition upon reduction, resulting in the
controlled release of 5-aminosalicylic acid as the anti-inflammatory agent. This methodology
will ultimately lead to new biomaterials for site-specific drug delivery.